Evidence map›Paper›PMID 16940080›Full record

ArticleAntimicrobial agents and chemotherapy2006

Evolution and global dissemination of macrolide-resistant group A streptococci.

D Ashley Robinson, Joyce A Sutcliffe, Wezenet Tewodros, Anand Manoharan, Debra E Bessen

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular epidemiology and genomics of group A Streptococcus.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2015
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Population biology of the human restricted pathogen, Streptococcus pyogenes.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2009
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

D Ashley RobinsonDepartment of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
Joyce A Sutcliffe
Wezenet Tewodros
Anand Manoharan
Debra E Bessen

Funding

Tissue-Specific Infection by Group A StreptococciR01AI053826 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2003 to 2007
$1.3M
EVOLUTION OF GROUP A STREPTOCOCCIR01GM060793 · NIGMS · YALE UNIVERSITY · PI BESSEN, DEBRA E · 2000 to 2004
$1.1M
Tissue-Specific Infection by Group A StreptococciR56AI053826 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2008 to 2009
$808k
Molecular Evolution of Resistance in Strep. pyogenesR21AI061454 · NIAID · NEW YORK MEDICAL COLLEGE · PI BESSEN, DEBRA E · 2004 to 2005
$429k
NIAID NIH HHS AI053826NIAID NIH HHS AI061454NIAID NIH HHS R01 AI053826NIAID NIH HHS R21 AI061454NIAID NIH HHS R56 AI053826NIGMS NIH HHS GM060793NIGMS NIH HHS R01 GM060793
6 · The paper itself

Abstract

Macrolide-resistant group A streptococci (MRGAS) have been recovered from many countries worldwide. However, the strain typing information that is available has been insufficient for estimating the total number of macrolide-resistant clones, their geographic distributions, and their evolutionary relationships. In this study, sequence-based strain typing was used to characterize 212 MRGAS isolates from 34 countries. Evaluation of clonal complexes, emm type, and resistance gene content [erm(A), erm(B), mef(A), and undefined] indicate that macrolide resistance was acquired by GAS organisms via > or independent genetic events. In contrast to other collections of mostly susceptible GAS, genetic diversification of MRGAS clones has occurred primarily by mutation rather than by recombination. Twenty-two MRGAS clonal complexes were recovered from more than one continent; intercontinental strains represent nearly 80% of the MRGAS isolates under study. The findings suggest that horizontal transfer of macrolide resistance genes to numerous genetic backgrounds and global dissemination of resistant clones and their descendants are both major components of the present-day macrolide resistance problem found within this species.

Indexed as

Biological EvolutionDrug Resistance, BacterialDisease Transmission, InfectiousGenetic VariationGene Transfer, HorizontalHumansMacrolidesStreptococcal InfectionsStreptococcus pyogenesVirulenceMacrolides

Identifiers

PMID16940080
PMCPMC1563541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.